Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease

Author(s): Olaf Eickmeier, Nikolaus Rieber, Jonas Eckrich, Andreas Hector, Ute Graeppler-Mainka and Dominik Hartl

Volume 19, Issue 20, 2013

Page: [3669 - 3678] Pages: 10

DOI: 10.2174/13816128113199990349

Price: $65

Abstract

Patients with cystic fibrosis (CF) suffer from chronic infective lung disease, which determines morbidity and mortality. While bacteria, such as Pseudomonas aeruginosa, are well-known to contribute to pulmonary pathology, the relevance of fungi in CF airways remains poorly understood. The best studied fungus in CF is Aspergillus fumigatus, which frequently colonizes CF airways and causes a disease condition termed allergic bronchopulmonary aspergillosis. This review aims to provide an update on the immunological mechanisms, diagnostic approaches and therapeutic strategies for allergic bronchopulmonary aspergillosis and other Aspergillus fumigatusmediated phenotypes in CF lung disease.

Keywords: Cystic fibrosis, Allergic Bronchopulmonary Aspergillosis (ABPA), Immune response.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy